Strength Seen in T2 Biosystems (TTOO): Stock Gains 9.6% – Tale of the Tape

Zacks

T2 Biosystems, Inc. (TTOO) was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock has lost almost 13% in the past one-month time frame.
This in vitro diagnostics company has seen no estimate revisions in the last 7 days. The Zacks Consensus Estimate has also remained unchanged over the same time frame. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
T2 Biosystems currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors looking for well-positioned medical instruments stocks may consider Alphatec Holdings, Inc. (ATEC), ERBA Diagnostics, Inc. (ERB) and Bacterin International Holdings, Inc. (BONE). While ATEC and ERB sport a Zacks Rank #1 (Strong Buy), BONE carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply